In several robust trials, a marked decrease in the incidence of acute respiratory disease, ischemic heart disease, hypertension disease, pulmonary fibrosis, coronary artery disease, diabetes mellitus, Alzeimers disease, deforming osteoarthrosis, and osteoporosis was observed as compared to control animals 6
These conditions may have soft tissue components that respond to treatment, but the underlying structural issues persist
Nitric oxide is an important signaling molecule involved in many biological processes at the cellular level
By reducing inflammation and supporting cholesterol balance, Finland research suggests that GHRP-2 promotes heart health and reduces the risk of cardiovascular conditions, fostering long-term systemic well-being (9)